Data Material
ALK Medical Affairs Canada provides the resources found on this website for Canadian healthcare professionals only.
A birch sublingual allergy immunotherapy tablet reduces rhinoconjunctivitis symptoms when exposed to birch and oak and induces IgG4 to allergens from all trees in the birch homologous group
Journal Publication
Click to view
By clicking here, you agree to visiting a site maintained by a third party, who is solely responsible for its contents.
Short Summary: This trial demonstrates that the SQ tree SLIT-tablet reduce ARC symptoms triggered by birch or oak pollen. The optimal dose for further development was 12 DU. Clinical and immunological findings suggest that the tablet may be used to treat allergies to all species within the birch homologous group.